Patents by Inventor Hans-Ulrich Naegeli

Hans-Ulrich Naegeli has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8183341
    Abstract: This invention relates to a novel antibiotic compounds, pharmaceutically acceptable salts and derivatives thereof, and to methods for obtaining such compounds.
    Type: Grant
    Filed: December 19, 2007
    Date of Patent: May 22, 2012
    Assignee: Novartis AG
    Inventors: Matthew J. Lamarche, Jennifer A. Leeds, Phillipp Krastel, Hans-Ulrich Naegeli
  • Publication number: 20100093615
    Abstract: This invention relates to a novel antibiotic compounds, pharmaceutically acceptable salts and derivatives thereof, and to methods for obtaining such compounds.
    Type: Application
    Filed: December 19, 2007
    Publication date: April 15, 2010
    Inventors: Matthew J. Lamarche, Jennifer A. Leeds, Phillipp Krastel, Hans-Ulrich Naegeli
  • Patent number: 6013627
    Abstract: Cyclopeptolides of formula I ##STR1## wherein A, B, R, Leu, Leu, C, X and Y are as defined, are inhibitors of adhesion molecule expression and are thus useful for treatment of inflammatory and other diseases which involve increased levels of adhesion molecule expression.
    Type: Grant
    Filed: January 24, 1997
    Date of Patent: January 11, 2000
    Assignee: Novartis AG
    Inventors: Michael Morris Dreyfuss, Carolyn Ann Foster, Hans-Ulrich Naegeli, Berndt Oberhauser
  • Patent number: 5852005
    Abstract: The present invention relates to 17 .alpha.-dammara compounds having immunosuppressant and antiinflammatory activity and which are useful as pharmaceuticals, particularly for use as immunosuppressant and antiinflammatory agents. Specific 17 .alpha.-dammara compounds are included per se, for example the compound of formula IC, i.e. 17 .alpha.-23-(E)-dammara-20, 23-dien-3.beta., 25-diol, which may be obtained from the flour of the shoots of the Palmyrah palm, Borassus flabellifer L. In addition, processes for the synthesis of this and other dammara compounds and intermediates thereof are described.
    Type: Grant
    Filed: January 24, 1997
    Date of Patent: December 22, 1998
    Assignee: Novartis AG
    Inventors: Peter Hiestand, Reto Naef, Hans-Ulrich Naegeli, Lukas Oberer, Laszlo Revesz, Hans-Jorg Roth
  • Patent number: 4406905
    Abstract: The invention relates especially to 2-(3'-hydroxypyrid-2'-yl)-2-thiazoline-4-carboxylic acid derivatives of the formula (I) and salts and also certain metal complexes of these compounds, processes for their manufacture, pharmaceutical agents containing such compounds and the use of these compounds. ##STR1## In the formula, R.sup.1 represents free, etherified or esterified hydroxy, R.sup.2 represents hydrogen or an aliphatic, carbocyclic or carbocyclic-aliphatic radical having 1-12 carbon atoms, and R.sup.3 represents hydrogen or an unsubstituted aliphatic radical having 1-7 carbon atoms.The compounds of the formula (I) can be used, for example, for the abstraction of heavy metals from the organism of warm-blooded animals and/or they have an antibiotic action.
    Type: Grant
    Filed: July 23, 1981
    Date of Patent: September 27, 1983
    Assignee: Ciba-Geigy Corporation
    Inventors: Hans Zahner, Hans-Ulrich Naegeli, Heinrich Peter